Dynavax Technologies | DŁUG

	Debt	Zmiana		Data
AbbVie	USD 67.14B		3.94B	2024-12
Adma Biologics	USD 72.34M		28.99M	2024-12
Amgen	USD 60.1B		299M	2024-12
AstraZeneca	USD 30.3B		1.27B	2024-12
Biogen	USD 6.3B		1.9M	2024-12
BioMarin Pharmaceutical	USD 596.24M		1.61M	2024-12
Bristol-Myers Squibb	USD 49.65B		103M	2024-12
Dynavax Technologies	USD 223.85M		293K	2024-12
Gilead Sciences	USD 26.71B		3.46B	2024-12
Glaxosmithkline	GBP 16.99B		927M	2024-12
Merck	USD 37.11B		1.02B	2024-12
Neurocrine Biosciences	USD 0		0	2024-12
Novartis	USD 31.26B		828M	2024-12
Pfizer	USD 64.35B		3.35B	2024-12
Regeneron Pharmaceuticals	USD 2.7B		400K	2024-12
Roche Holding	CHF 34.44B		5.23B	2024-06
Sarepta Therapeutics	USD 1.14B		90.44M	2024-12
TG Therapeutics	USD 244.43M		271K	2024-12
Vertex Pharmaceuticals	USD 112.8M		1.2M	2024-12

Dynavax Technologies DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.